Back
Apellis Pharmaceuticals Vs. Innodata Industry Stock Comparison
Sell
31
APLS
Apellis Pharmaceuticals
Last Price:
$19.59
Seasonality Move:
-8.3%
Buy
64
INOD
Innodata
Last Price:
$49.11
Seasonality Move:
4.31%
Sell
31
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $19.59. The Score for APLS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $19.59The current trend is moderately bullish and APLS is experiencing slight selling pressure.
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.41 | Buy |
Relative Strength Index (14 RSI): | 54.73 | Buy |
Chaikin Money Flow: | -1363320 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.86 - 19.76) | Buy |
Bollinger Bands (100): | (17.19 - 22.45) | Sell |
INOD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 11.55 | Buy |
Relative Strength Index (14 RSI): | 53.27 | Buy |
Chaikin Money Flow: | 1469530 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.34 - 51.02) | Buy |
Bollinger Bands (100): | (36.12 - 48.36) | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.75 | Sell |
20-day SMA: | 18.97 | Buy |
50-day SMA: | 18.45 | Buy |
200-day SMA: | 24.83 | Sell |
8-day EMA: | 19.67 | Sell |
20-day EMA: | 19.24 | Buy |
50-day EMA: | 19.13 | Buy |
200-day EMA: | 25.25 | Sell |
INOD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.29 | Buy |
20-day SMA: | 49.38 | Sell |
50-day SMA: | 45.14 | Buy |
200-day SMA: | 39.26 | Buy |
8-day EMA: | 46.8 | Buy |
20-day EMA: | 36.78 | Buy |
50-day EMA: | 21.07 | Buy |
200-day EMA: | 6.44 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.39 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
Innodata Earnings Growth & INOD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.06 per share, and an increase next year of $0.40 per share.
Apellis Pharmaceuticals Technical Analysis
Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Innodata Technical Analysis
Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |